Sean McCutcheon
Stock Analyst at Raymond James
(3.11)
Main Sectors:
Top Industries:
9 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RVMD Revolution Medicines | Assumes: Strong Buy | 72 | 46.71 | 54.14% | 1 | Sep 12, 2025 | |
VIR Vir Biotechnology | Initiates Coverage On: Outperform | 12 | 5.73 | 109.42% | 1 | Jul 11, 2025 | |
JANX Janux Therapeutics | Initiates Coverage On: Outperform | 65 | 24 | 170.83% | 1 | Jul 11, 2025 | |
CMPX Compass Therapeutics | Reinstates: Outperform | 9 | 3.7 | 143.24% | 1 | Jul 1, 2025 | |
BDTX Black Diamond Therap... | Reinstates: Outperform | 11 | 3.89 | 182.78% | 1 | Jul 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 23 | 7.75 | 196.77% | 1 | Nov 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 58 40 | 11.77 | 239.85% | 1 | Jun 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 70 | 56.97 | 22.87% | 2 | May 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 86 | 32.06 | 168.25% | 1 | Mar 13, 2024 |